Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Lindquist

Showing results (171-180 of 183) with videos related to

Pageof 19
Sort By:
Science (New York, N.Y.)|June 24, 2006
Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's modelsAntony A Cooper, Aaron D Gitler, Anil Cashikar, et al.
Nature Communications|January 26, 2019
Structural basis for species-selective targeting of Hsp90 in a pathogenic fungusLuke Whitesell, Nicole Robbins, David S Huang, et al.
Disease Models & Mechanisms|December 30, 2009
Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease modelsLinhui Julie Su, Pavan K Auluck, Tiago Fleming Outeiro, et al.
Science (New York, N.Y.)|October 26, 2013
Identification and rescue of α-synuclein toxicity in Parkinson patient-derived neuronsChee Yeun Chung, Vikram Khurana, Pavan K Auluck, et al.
Science (New York, N.Y.)|October 29, 2011
Functional links between Aβ toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeastSebastian Treusch, Shusei Hamamichi, Jessica L Goodman, et al.
Science Translational Medicine|May 22, 2015
The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogsJonathan D Herman, Lauren R Pepper, Joseph F Cortese, et al.
Molecular Systems Biology|April 24, 2016
An inter-species protein-protein interaction network across vast evolutionary distanceQuan Zhong, Samuel J Pevzner, Tong Hao, et al.
Cell|June 10, 2022
The Parkinson's disease protein alpha-synuclein is a modulator of processing bodies and mRNA stabilityErinc Hallacli, Can Kayatekin, Sumaiya Nazeen, et al.
Cell Systems|January 30, 2017
Genome-Scale Networks Link Neurodegenerative Disease Genes to α-Synuclein through Specific Molecular PathwaysVikram Khurana, Jian Peng, Chee Yeun Chung, et al.
Molecular Cell|December 12, 2018
Lipidomic Analysis of α-Synuclein Neurotoxicity Identifies Stearoyl CoA Desaturase as a Target for Parkinson TreatmentSaranna Fanning, Aftabul Haque, Thibaut Imberdis, et al.
Pageof 19

Showing results (171-180 of 183) with videos related to

Sort By:
Pageof 19
Science (New York, N.Y.)|June 24, 2006
Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's modelsAntony A Cooper, Aaron D Gitler, Anil Cashikar, et al.
Nature Communications|January 26, 2019
Structural basis for species-selective targeting of Hsp90 in a pathogenic fungusLuke Whitesell, Nicole Robbins, David S Huang, et al.
Disease Models & Mechanisms|December 30, 2009
Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease modelsLinhui Julie Su, Pavan K Auluck, Tiago Fleming Outeiro, et al.
Science (New York, N.Y.)|October 26, 2013
Identification and rescue of α-synuclein toxicity in Parkinson patient-derived neuronsChee Yeun Chung, Vikram Khurana, Pavan K Auluck, et al.
Science (New York, N.Y.)|October 29, 2011
Functional links between Aβ toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeastSebastian Treusch, Shusei Hamamichi, Jessica L Goodman, et al.
Science Translational Medicine|May 22, 2015
The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogsJonathan D Herman, Lauren R Pepper, Joseph F Cortese, et al.
Molecular Systems Biology|April 24, 2016
An inter-species protein-protein interaction network across vast evolutionary distanceQuan Zhong, Samuel J Pevzner, Tong Hao, et al.
Cell|June 10, 2022
The Parkinson's disease protein alpha-synuclein is a modulator of processing bodies and mRNA stabilityErinc Hallacli, Can Kayatekin, Sumaiya Nazeen, et al.
Cell Systems|January 30, 2017
Genome-Scale Networks Link Neurodegenerative Disease Genes to α-Synuclein through Specific Molecular PathwaysVikram Khurana, Jian Peng, Chee Yeun Chung, et al.
Molecular Cell|December 12, 2018
Lipidomic Analysis of α-Synuclein Neurotoxicity Identifies Stearoyl CoA Desaturase as a Target for Parkinson TreatmentSaranna Fanning, Aftabul Haque, Thibaut Imberdis, et al.
Pageof 19